[Cancer Research UK] Stage 1 EOI: Therapeutic Catalyst
An SME cannot be the lead applicant for this award. The lead must be a researcher based at a UK research organisation that can hold a Cancer Research UK award. SMEs and industry partners can be involved as collaborators, providing expertise, technology, services or development capability, as long as their role and budget are clearly described in the proposal. Purpose The Therapeutic Catalyst award is designed to accelerate the development of novel therapeutic approaches that have clear potential to become new cancer treatments. It supports projects that aim to generate key data to move a ther…
Next deadline
Last round closed: 25 August 2026
What it funds
An SME cannot be the lead applicant for this award. The lead must be a researcher based at a UK research organisation that can hold a Cancer Research UK award. SMEs and industry partners can be involved as collaborators, providing expertise, technology, services or development capability, as long as their role and budget are clearly described in the proposal. Purpose The Therapeutic Catalyst award is designed to accelerate the development of novel therapeutic approaches that have clear potential to become new cancer treatments. It supports projects that aim to generate key data to move a ther…
Who it suits
An SME cannot be the lead applicant for this award. The lead must be a researcher based at a UK research organisation that can hold a Cancer Research UK award. SMEs and industry partners can be involved as collaborators, providing expertise, technology, services or development capability, as long a…
- Life sciences & health
- Manufacturing & materials
- Feasibility
- Late stage & scale-up
Programme specifications
Considering [Cancer Research UK] Stage 1 EOI: Therapeutic Catalyst?
Talk through your project with a specialist and find out whether this is the right competition before you invest time in an application.